Targeting the growth hormone axis as a therapeutic strategy in oncology.
Friend
K E
KE
University of Texas M. D. Anderson Cancer Center, Houston, USA.
D013006:Growth Hormone / Q000096:biosynthesis*; D013007:Growth Hormone-Releasing Hormone / Q000037:antagonists & inhibitors; D006801:Humans; D018969:Insulin-Like Growth Factor Binding Proteins / Q000627:therapeutic use; D007334:Insulin-Like Growth Factor I / Q000096:biosynthesis*; D009369:Neoplasms / Q000188:drug therapy*; D017526:Receptor, IGF Type 1 / Q000235:genetics / Q000276:immunology; D011986:Receptors, Somatotropin / Q000037:antagonists & inhibitors; D013004:Somatostatin / Q000031:analogs & derivatives / Q000494:pharmacology
D018969:Insulin-Like Growth Factor Binding Proteins; D011986:Receptors, Somatotropin; D013004:Somatostatin; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone; D013007:Growth Hormone-Releasing Hormone; D017526:Receptor, IGF Type 1